Molecular Diagnostics
Recombinant ELISAs Increase Efficiency of CMV Serodiagnosis in Pregnant Women
Cytomegalovirus (CMV) is a virus that is prevalent across the world and poses a significant risk during pregnancy due to vertical transmission to the fetus. Now, the findings of a new study could have significant practical relevance by reducing the laboratory workload and the costs involved in maternal CMV serodiagnostics. More...20 Feb 2023
Novel Esophageal Cancer Test Could Reduce Unnecessary Endoscopies
Esophageal cancer is a highly lethal form of cancer, with an overall five-year survival rate of less than 20%. Now, a mass spectrometry-based test that, once clinically validated, could diagnose pre-cancerous cells years earlier than current standard diagnostic protocols for esophageal cancer, as well as reduce unnecessary endoscopies. More...20 Feb 2023
Non-Invasive Stool Test Could Diagnose Early Form of Parkinson’s Disease
In body-first Parkinson’s disease (PD), the characteristic deposits of aggregates of the body’s own α-synuclein protein are formed in the neurons in the intestine. Now, a research team has shown that a higher concentration of α-synuclein aggregates can be detected in the stool samples of PD patients. More...17 Feb 2023
Benchtop Multiplex Genetic Analyzer Helps Target, Identify, and Confirm Clinically Relevant Mutations
Laboratories are required to maintain an efficient lab workflow in order to ensure the integrity of results. Now, a benchtop multiplex genetic analyzer empowers high-throughput testing by automating key aspects of sample preparation while providing laboratories with the flexibility to customize their extraction and sample preparation protocols. More...17 Feb 2023
New Technique Designs Nucleic Acid Probes to Detect Rapidly Mutating Bacteria and Viruses
Researchers have developed a technique called AutoPLP that designs nucleic acid probes to help quickly, accurately and easily detect new variants of pathogens which can be hard to trace. This could help prevent infections that have the potential to spread quickly due to these dangerous variants. More...16 Feb 2023
New Study to Help Identify Accurate microRNA Biomarkers for Early Detection and Treatment of Diabetes
Over the past two decades, researchers have conducted studies with animal or cell-based models which have suggested that specific small RNA molecules, called microRNAs, involved in controlling which genes are turned on and off in cells could help pancreatic islets develop and function normally. However, the specific role of these microRNAs in human pancreatic islets was poorly characterized. Now, a new large-scale genetic analysis has identified a set of microRNAs in pancreatic islets that are strongly associated with type 2 diabetes. More...14 Feb 2023
D-Dimer Blood Test Detects Prosthetic Joint Infections as Accurately as Standard Tests
Plasma D-dimer, a test commonly used for certain blood clot-related disorders, is a potentially useful marker of infection and has been validated for use in the diagnosis of periprosthetic joint infection (PJI). However, some studies have raised concerns over the diagnostic performance of D-dimer testing for PJI, and its true accuracy is still unknown. Now, a new study suggests that the measurement of plasma D-dimer levels can provide useful information when making the difficult diagnosis of PJI. More...13 Feb 2023
Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
In Other News
New Diagnostic Test 1,000 Times More Sensitive than Conventional Tests
Unique Biomarker Could Lead to Diagnostic Tests for Detection of Early-Stage Alzheimer’s
Voice-Activated Sample Pre-Treatment Device Enables Hands-Free, Safer DNA Handling
World’s First AI-Powered Diagnostic Test Accurately Identifies Respiratory Viruses in Five Minutes
New Blood Test Detects Prostate Cancer With 94% Accuracy
World’s First Comprehensive Risk Test for Breast & Ovarian Cancer Launched
New Assay Determines if Bladder Cancer Patients Need Radical Surgery
Urine Prostate Cancer Screening Test Offers Best-In-Class Accuracy and Stratified Risk Assessment
Nanotechnology-Based Blood Test Could Revolutionize Prostate Cancer Diagnosis
New Device Detects Brain Tumors Using Urine
New Blood Test Could Ensure Timely Life-Saving Treatment of Heart Attack Victims
Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing
Focused-Ultrasound-Mediated Liquid Biopsy to Facilitate Diagnosis of Neurodegenerative Disorders
Blood Test Predicts Alzheimer's Risk 3.5 Years Before Clinical Diagnosis
Novel Biomarker-Based Tests to Predict Response to Drugs for Treatment of Chronic Kidney Disease
Newly Identified Protein Biomarkers in Blood Predict Sudden Cardiac Arrest Before it Strikes
Blood Test Identifies Osteoarthritis Progression More Accurately than Current Methods
New DNA Biosensor Could Make High-Quality Clinical Diagnostics More Accessible
New Technique Enables Measurement of Thousands of Molecules from Single Blood Drop
Non-Invasive Blood Test Helps Select Treatment for Advanced Gastrointestinal Stromal Tumors
Non-Invasive Melanoma Test Ushers in New Era in Skin Cancer Detection
World’s First Molecular, Cell-Based Test Offers Non-Surgical Method for Diagnosis and Staging of Endometriosis
Rapid POC Diagnostic Assay Could Detect and Measure Fentanyl Neutralizing Antibodies
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.